In April, 2025, Demis Hassabis, the Nobel Prize-winning CEO of Google DeepMind, appeared on the US television show 60 Minutes and suggested that all diseases could be curable with the help of ...

The Trump Administration released America’s AI Action Plan (the “Plan”) on July 23, 2025, a comprehensive strategy to attempt to “win” the race to achieve global dominance in artificial intelligence ( ...

AI was supposed to boost drug discovery, but progress has stalled. Learn why the hype hasn’t delivered and what needs to ...

Food dyes are known to have a wide range of impacts on health, such as cancer risks, behavioral problems in children, and ...

On July 24, 2025, the White House released the “White House AI Action Plan,” which includes over 90 policy actions focused on accelerating innovation, building AI infrastructure, and increasing ...

Atai Life Sciences and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with schizophrenia-linked cognitive ...

Hims & Hers (NYSE:HIMS) stock slips as U.S. lawmakers seek FDA action against copycat versions of weight loss drugs from Novo ...

Sarepta and Roche face a regulatory setback as the EMA's CHMP issues a negative opinion on Elevidys for Duchenne muscular ...

Xuewu Liu, a Chinese inventor who has no medical training or credentials of any kind, is charging cancer patients $20,000 for ...

A Chinese man with no medical training is injecting cancer patients with a toxic bleach solution; a full course of treatment ...

In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...

On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in ...